Unicity International Announces Issuance of a Composition of Matter Patent for Its Gene Regulation Technology
Unicity s innovative patented composition is designed to support proper gene expression
News provided by
Share this article
Share this article
OREM, Utah, Feb. 25, 2021 /PRNewswire/ Unicity International, a leader in global nutrition and metabolic health solutions, has been issued a US patent for an innovative process in its Genomeceutical technology: US Pat. No. 10,426,756 B2. Unicity International R&D scientists submitted the patent application on August 21, 2019.
The patented composition consists of 10 secondary metabolites. Secondary metabolites are phytochemicals that contain bioactive compounds scientific research has shown that these bioactive compounds can help maintain healthy gene expression in the body.